Phi Optics Inc was founded in 2009 to respond to market’s request for QPI enabled devices. The company is developing the next generation of optical imaging systems through its Quantitative Phase Imaging Platform. Phi Optics platform is aimed at augmenting conventional optical microscopy in various vertical markets. Backed by an extensive patent portfolio secured both through in-licensing and continued developments at Phi Optics, the company is targeting applications in life sciences, medical diagnostics, nanotechnology, and semiconductor testing.
Phi Optics technology platform uses standard tools and processes and combines the performance of traditional modalities of an light microscope (e.g. fluorescence, DIC, phase contrast) with the real-time 3D topography capabilities of QPI. This combination offers a significant advantage for applications that require low-cost, fast and accurate imaging of nanostructures.